News

Walgreens, Roush Fenway Racing partner on promoting Walgreens’ prepaid MasterCard

BY Michael Johnsen

DEERFIELD, Ill. — Walgreens and Roush Fenway Racing recenty launched a partnership to stage “The Race Around America” Interactive Promotion, presented by Balance Financial Prepaid MasterCard from Walgreens.

The multi-faceted campaign will be fueled by fan interaction and will culminate with the awarding of the grand prize — the fully-enhanced Roush Stage 3 Mustang used in the promotion by Roush Fenway drivers.

Fans have already dictated the Mustang’s design to be used during the promotion through online voting, selecting a patriotic design scheme as the fan favorite. “The eye-catching design reflects the patriotism for which NASCAR fans are well known, and we are proud that our Race Around America Mustang will sport red, white and blue, so fitting for one of America’s greatest auto brands,” said John Schmidtke, manager, Walgreens loyalty marketing. 

By registering their cards for the promotion, Balance Financial Card cardholders will be entered in the sweepstakes. Cardholders can earn additional automatic entries — up to five times per day — by making a purchase or reloading their Balance Financial Cards. Consumers can enter between Feb. 23 and Oct. 15, 2014. 

Throughout the promotion, Roush Fenway Racing drivers Greg Biffle, Ryan Reed, Trevor Bayne and Chris Buescher will drive the Mustang from a concluding NASCAR race city to the next, making pit stops to meet with fans along the way. Webisodes from the drivers’ journeys will be produced, as well. 

The Balance Financial Prepaid MasterCard from Walgreens is the safe alternative to cash that’s big on convenience and small on fees. Fans who purchase the Card will unlock features like earning Balance Rewards points faster just for using the Card.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Glade gets ready for spring

BY Ryan Chavis

RACINE, Wis. — Just as the winter months draw to a close, SC Johnson’s Glade brand announced a line of new spring-inspired scents, which the company said will evoke the excitement of the change of seasons.

The Glade Limited Edition Spring Collection consists of five new fragrances:

  • Lift off: A floral scent with hints of white tea and magnolia;
  • Live Loud: A bold floral fragrance with hints of rosehip and plumeria;
  • Splash Out: A blend of blackberry notes;
  • Let Loose: A mix of kiwi and wild peach; and
  • Dig It: A citrus and sunflower fragrance.

The collection is available in 4-oz. candle jars, room sprays, PlugIns Scented Oil refills and Wax Melts.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

McKesson names new independent director

BY Michael Johnsen

SAN FRANCISCO — McKesson on Wednesday announced that its board of directors has elected Anthony Coles as a new independent director, effective April 29, 2014. In connection with Coles’ election, the size of the board of directors was increased from nine to 10 members, nine of whom are independent.

“With over 20 years of experience in the biopharmaceuticals and pharmaceutical industries, including several public company leadership positions, Tony will provide unique perspectives that will further diversify the expertise of our board,” said John Hammergren, chairman and CEO McKesson.  “We are committed to maintaining the best possible leadership team to continue guiding our strong financial performance. The addition of Tony to our board represents a continuation of initiatives already under way to address shareholder feedback and maintain industry-leading governance practices.”

The board has appointed Coles as a member of its compensation and finance committees. Coles’ term as a director will expire at the company’s 2014 Annual Meeting of Stockholders unless he is renominated as a director, and elected by stockholders at the annual meeting in accordance with McKesson’s majority voting standard.

Coles, 53, was president, CEO and chairman of the board of Onyx Pharmaceuticals, a biopharmaceutical company, from 2012 until 2013, having served as its president and CEO, and a member of its board of directors, from 2008 until 2012. From 2005 to 2008, Coles served as an executive and a director of NPS Pharmaceuticals, a public biopharmaceutical company. Coles began his tenure at NPS as president and COO and ended his tenure there as president and CEO. Prior to 2005, Coles served in various leadership positions in the biopharmaceutical and pharmaceutical industries, including at Merck, Bristol-Myers Squibb Company and Vertex Pharmaceuticals.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES